AU Stock MarketDetailed Quotes

PAR Paradigm Biopharmaceuticals Ltd

Watchlist
  • 0.305
  • +0.005+1.67%
20min DelayNot Open Jul 17 16:00 AET
106.86MMarket Cap-1703P/E (Static)

Paradigm Biopharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
(FY)Jun 30, 2021
(Q4)Jun 30, 2021
(FY)Jun 30, 2020
(Q4)Jun 30, 2020
(FY)Jun 30, 2019
(Q4)Jun 30, 2019
Assets
Current assets
Cash, cash equivalents and short term investments
41.99%56.33M
41.99%56.33M
-44.15%39.67M
-44.15%39.67M
-31.65%71.03M
-31.65%71.03M
31.82%103.92M
31.82%103.92M
3,123.55%78.84M
3,123.55%78.84M
-Cash and cash equivalents
41.99%56.33M
41.99%56.33M
-44.15%39.67M
-44.15%39.67M
-31.65%71.03M
-31.65%71.03M
43.67%103.92M
43.67%103.92M
2,857.77%72.34M
2,857.77%72.34M
-Accounts receivable
----
----
-10.79%18.33K
-10.79%18.33K
--20.55K
--20.55K
----
----
----
----
-Notes receivable
47.77%112.83K
47.77%112.83K
-29.44%76.36K
-29.44%76.36K
58.22%108.21K
58.22%108.21K
--68.39K
--68.39K
----
----
-Other receivables
----
----
----
----
----
----
0.00%36.59K
0.00%36.59K
0.00%36.59K
0.00%36.59K
Holding assets for sale
0.00%46.2K
0.00%46.2K
0.00%46.2K
0.00%46.2K
-93.81%46.2K
-93.81%46.2K
--746.2K
--746.2K
----
----
Total current assets
35.22%63.79M
35.22%63.79M
-41.75%47.17M
-41.75%47.17M
-25.28%80.98M
-25.28%80.98M
31.35%108.37M
31.35%108.37M
1,464.86%82.51M
1,464.86%82.51M
Non current assets
-Accumulated depreciation
-13.32%-689.6K
-13.32%-689.6K
-46.54%-608.51K
-46.54%-608.51K
-101.53%-415.26K
-101.53%-415.26K
-585.44%-206.06K
-585.44%-206.06K
-16.47%-30.06K
-16.47%-30.06K
-Long term equity investment
-49.52%236.69K
-49.52%236.69K
-24.03%468.91K
-24.03%468.91K
-17.59%617.23K
-17.59%617.23K
--748.96K
--748.96K
----
----
-Goodwill
0.00%2.95M
0.00%2.95M
0.00%2.95M
0.00%2.95M
0.00%2.95M
0.00%2.95M
-1.13%2.95M
-1.13%2.95M
-69.92%2.98M
-69.92%2.98M
Regulatory assets
1.32%6.81M
1.32%6.81M
-21.03%6.72M
-21.03%6.72M
142.40%8.51M
142.40%8.51M
-0.64%3.51M
-0.64%3.51M
29.16%3.53M
29.16%3.53M
Liabilities
Current liabilities
Current debt and capital lease obligation
-28.96%104.97K
-28.96%104.97K
9.76%147.76K
9.76%147.76K
7.93%134.62K
7.93%134.62K
--124.73K
--124.73K
----
----
-Current capital lease obligation
-28.96%104.97K
-28.96%104.97K
9.76%147.76K
9.76%147.76K
7.93%134.62K
7.93%134.62K
--124.73K
--124.73K
----
----
-accounts payable
71.57%12.16M
71.57%12.16M
42.15%7.09M
42.15%7.09M
81.47%4.99M
81.47%4.99M
20.55%2.75M
20.55%2.75M
121.27%2.28M
121.27%2.28M
-Total tax payable
-35.90%349.52K
-35.90%349.52K
-24.84%545.27K
-24.84%545.27K
-11.25%725.43K
-11.25%725.43K
--817.35K
--817.35K
--0
--0
Current liabilities
66.55%13.04M
66.55%13.04M
35.17%7.83M
35.17%7.83M
72.19%5.79M
72.19%5.79M
24.40%3.36M
24.40%3.36M
103.80%2.7M
103.80%2.7M
Non current liabilities
-Long term debt
-49.52%236.69K
-49.52%236.69K
-24.03%468.91K
-24.03%468.91K
-17.59%617.23K
-17.59%617.23K
--748.96K
--748.96K
----
----
Non current accrued expenses
-41.10%336.39K
-41.10%336.39K
-25.28%571.16K
-25.28%571.16K
-18.92%764.41K
-18.92%764.41K
3,823.72%942.83K
3,823.72%942.83K
181.30%24.03K
181.30%24.03K
Employee benefits
47.77%112.83K
47.77%112.83K
-29.44%76.36K
-29.44%76.36K
58.22%108.21K
58.22%108.21K
--68.39K
--68.39K
----
----
Preferred securities outside stock equity
30.46%776.2K
30.46%776.2K
-11.52%594.96K
-11.52%594.96K
47.62%672.4K
47.62%672.4K
17.22%455.51K
17.22%455.51K
49.25%388.59K
49.25%388.59K
Total non current liabilities
59.88%13.39M
59.88%13.39M
28.49%8.38M
28.49%8.38M
55.88%6.52M
55.88%6.52M
54.62%4.18M
54.62%4.18M
103.80%2.7M
103.80%2.7M
Shareholders'equity
Share capital
42.56%209.83M
42.56%209.83M
0.14%147.19M
0.14%147.19M
0.77%146.99M
0.77%146.99M
33.25%145.87M
33.25%145.87M
311.03%109.47M
311.03%109.47M
-common stock
42.56%209.83M
42.56%209.83M
0.14%147.19M
0.14%147.19M
0.77%146.99M
0.77%146.99M
33.25%145.87M
33.25%145.87M
311.03%109.47M
311.03%109.47M
Gains losses not affecting retained earnings
-19.44%7.36M
-19.44%7.36M
40.25%9.13M
40.25%9.13M
81.64%6.51M
81.64%6.51M
-11.97%3.59M
-11.97%3.59M
74.15%4.07M
74.15%4.07M
Total equity
32.32%67.07M
32.32%67.07M
-40.22%50.69M
-40.22%50.69M
-24.54%84.79M
-24.54%84.79M
31.40%112.36M
31.40%112.36M
462.90%85.51M
462.90%85.51M
(FY)Jun 30, 2023(Q4)Jun 30, 2023(FY)Jun 30, 2022(Q4)Jun 30, 2022(FY)Jun 30, 2021(Q4)Jun 30, 2021(FY)Jun 30, 2020(Q4)Jun 30, 2020(FY)Jun 30, 2019(Q4)Jun 30, 2019
Assets
Current assets
Cash, cash equivalents and short term investments 41.99%56.33M41.99%56.33M-44.15%39.67M-44.15%39.67M-31.65%71.03M-31.65%71.03M31.82%103.92M31.82%103.92M3,123.55%78.84M3,123.55%78.84M
-Cash and cash equivalents 41.99%56.33M41.99%56.33M-44.15%39.67M-44.15%39.67M-31.65%71.03M-31.65%71.03M43.67%103.92M43.67%103.92M2,857.77%72.34M2,857.77%72.34M
-Accounts receivable ---------10.79%18.33K-10.79%18.33K--20.55K--20.55K----------------
-Notes receivable 47.77%112.83K47.77%112.83K-29.44%76.36K-29.44%76.36K58.22%108.21K58.22%108.21K--68.39K--68.39K--------
-Other receivables ------------------------0.00%36.59K0.00%36.59K0.00%36.59K0.00%36.59K
Holding assets for sale 0.00%46.2K0.00%46.2K0.00%46.2K0.00%46.2K-93.81%46.2K-93.81%46.2K--746.2K--746.2K--------
Total current assets 35.22%63.79M35.22%63.79M-41.75%47.17M-41.75%47.17M-25.28%80.98M-25.28%80.98M31.35%108.37M31.35%108.37M1,464.86%82.51M1,464.86%82.51M
Non current assets
-Accumulated depreciation -13.32%-689.6K-13.32%-689.6K-46.54%-608.51K-46.54%-608.51K-101.53%-415.26K-101.53%-415.26K-585.44%-206.06K-585.44%-206.06K-16.47%-30.06K-16.47%-30.06K
-Long term equity investment -49.52%236.69K-49.52%236.69K-24.03%468.91K-24.03%468.91K-17.59%617.23K-17.59%617.23K--748.96K--748.96K--------
-Goodwill 0.00%2.95M0.00%2.95M0.00%2.95M0.00%2.95M0.00%2.95M0.00%2.95M-1.13%2.95M-1.13%2.95M-69.92%2.98M-69.92%2.98M
Regulatory assets 1.32%6.81M1.32%6.81M-21.03%6.72M-21.03%6.72M142.40%8.51M142.40%8.51M-0.64%3.51M-0.64%3.51M29.16%3.53M29.16%3.53M
Liabilities
Current liabilities
Current debt and capital lease obligation -28.96%104.97K-28.96%104.97K9.76%147.76K9.76%147.76K7.93%134.62K7.93%134.62K--124.73K--124.73K--------
-Current capital lease obligation -28.96%104.97K-28.96%104.97K9.76%147.76K9.76%147.76K7.93%134.62K7.93%134.62K--124.73K--124.73K--------
-accounts payable 71.57%12.16M71.57%12.16M42.15%7.09M42.15%7.09M81.47%4.99M81.47%4.99M20.55%2.75M20.55%2.75M121.27%2.28M121.27%2.28M
-Total tax payable -35.90%349.52K-35.90%349.52K-24.84%545.27K-24.84%545.27K-11.25%725.43K-11.25%725.43K--817.35K--817.35K--0--0
Current liabilities 66.55%13.04M66.55%13.04M35.17%7.83M35.17%7.83M72.19%5.79M72.19%5.79M24.40%3.36M24.40%3.36M103.80%2.7M103.80%2.7M
Non current liabilities
-Long term debt -49.52%236.69K-49.52%236.69K-24.03%468.91K-24.03%468.91K-17.59%617.23K-17.59%617.23K--748.96K--748.96K--------
Non current accrued expenses -41.10%336.39K-41.10%336.39K-25.28%571.16K-25.28%571.16K-18.92%764.41K-18.92%764.41K3,823.72%942.83K3,823.72%942.83K181.30%24.03K181.30%24.03K
Employee benefits 47.77%112.83K47.77%112.83K-29.44%76.36K-29.44%76.36K58.22%108.21K58.22%108.21K--68.39K--68.39K--------
Preferred securities outside stock equity 30.46%776.2K30.46%776.2K-11.52%594.96K-11.52%594.96K47.62%672.4K47.62%672.4K17.22%455.51K17.22%455.51K49.25%388.59K49.25%388.59K
Total non current liabilities 59.88%13.39M59.88%13.39M28.49%8.38M28.49%8.38M55.88%6.52M55.88%6.52M54.62%4.18M54.62%4.18M103.80%2.7M103.80%2.7M
Shareholders'equity
Share capital 42.56%209.83M42.56%209.83M0.14%147.19M0.14%147.19M0.77%146.99M0.77%146.99M33.25%145.87M33.25%145.87M311.03%109.47M311.03%109.47M
-common stock 42.56%209.83M42.56%209.83M0.14%147.19M0.14%147.19M0.77%146.99M0.77%146.99M33.25%145.87M33.25%145.87M311.03%109.47M311.03%109.47M
Gains losses not affecting retained earnings -19.44%7.36M-19.44%7.36M40.25%9.13M40.25%9.13M81.64%6.51M81.64%6.51M-11.97%3.59M-11.97%3.59M74.15%4.07M74.15%4.07M
Total equity 32.32%67.07M32.32%67.07M-40.22%50.69M-40.22%50.69M-24.54%84.79M-24.54%84.79M31.40%112.36M31.40%112.36M462.90%85.51M462.90%85.51M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg